000763666 000__ 06816cam\a2200457Ii\4500
000763666 001__ 763666
000763666 005__ 20230306142449.0
000763666 006__ m\\\\\o\\d\\\\\\\\
000763666 007__ cr\cn\nnnunnun
000763666 008__ 161102s2016\\\\ja\\\\\\ob\\\\001\0\eng\d
000763666 019__ $$a962017239$$a962153173$$a962436644
000763666 020__ $$a9784431560685$$q(electronic book)
000763666 020__ $$a4431560688$$q(electronic book)
000763666 020__ $$z9784431560661
000763666 020__ $$z4431560661
000763666 035__ $$aSP(OCoLC)ocn961909936
000763666 035__ $$aSP(OCoLC)961909936$$z(OCoLC)962017239$$z(OCoLC)962153173$$z(OCoLC)962436644
000763666 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dIDEBK$$dYDX$$dAZU$$dEBLCP
000763666 049__ $$aISEA
000763666 050_4 $$aRB131
000763666 08204 $$a616/.0473$$223
000763666 24500 $$aChronic inflammation :$$bmechanisms and regulation /$$cMasayuki Miyasaka, Kiyoshi Takatsu, editors.
000763666 264_1 $$a[Tokyo] :$$bSpringer,$$c2016.
000763666 300__ $$a1 online resource
000763666 336__ $$atext$$btxt$$2rdacontent
000763666 337__ $$acomputer$$bc$$2rdamedia
000763666 338__ $$aonline resource$$bcr$$2rdacarrier
000763666 504__ $$aIncludes bibliographical references and index.
000763666 5050_ $$aPart 1. Basic mechanisms underlying induction, progression, and resolution of chronic inflammation -- 1 Prostaglandins in chronic inflammation -- 2 Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis -- 3 Sema4A and chronic inflammation -- 4 MicroRNAs in Chronic Inflammation Diseases -- 5 Genetic dissection of autoinflammatory syndrome -- 6 Structural biology of chronic inflammation-associated signaling pathways: toward structure-guided drug development -- 7 Lipid signals in the resolution of inflammation -- 8 Regulation of chronic inflammation by control of macrophage activation and polarization -- 9 Clarification of the molecular mechanisms that negatively regulate inflammatory responses -- 10 The Drosophila Toll pathway: a model of innate immune signaling activated by endogenous ligands -- Part 2. Imaging analyses of chronic inflammation -- 11 Macrophage dynamics during bone resorption and chronic inflammation -- 12 Development of imaging mass spectrometry techniques for visualizing localized cellular signaling mediators in tissues -- 13 Tracking of follicular T cell dynamics during immune responses and inflammation -- Part 3. Chronic inflammation and cancer -- 14 The role of chronic inflammation in the promotion of gastric tumorigenesis -- 15 Cellular senescence as a novel mechanism of chronic inflammation and cancer progression -- 16 Establishment of diagnosis for early metastasis -- 17 Non-autonomous tumor progression by oncogenic inflammation -- 18 Inflammation-associated carcinogenesis mediated by the impairment of microRNA function in the gastroenterological organs -- 19 Roles of Epstein-Barr virus micro RNAs in Epstein-Barr virus-associated malignancies -- Part 4. Chronic inflammation and obesity/environmental stress -- 20 Chronicity of immune abnormality in atopic dermatitis: Interacting surface between environment and immune system -- 21 Role of double-stranded RNA pathways in immunometabolism in obesity -- 22 Molecular mechanisms underlying obesity-induced chronic inflammation -- 23 Roles of mitochondrial sensing and stress response in the regulation of inflammation -- 24 Oxidative stress regulation by reactive cysteine persulfides in inflammation -- Part 5. Chronic inflammation and innate immunity -- 25 Post-transcriptional Regulation of Cytokine mRNA Controls the Initiation and Resolution of Inflammation -- 26 Roles of C-type Lectin Receptors in Inflammatory Responses -- 27 Elucidation and control of the mechanisms underlying chronic inflammation mediated by invariant natural killer T cells -- 28 Understanding of the role of plasmacytoid dendritic cells in the control of inflammation and T-cell immunity -- 29 Mechanisms of lysosomal exocytosis by immune cells -- 30 Potential Therapeutic Natural Products for the Treatment of Obesity-associated Chronic Inflammation by Targeting TLRs and Inflammasomes -- Part 6. Chronic inflammation and adaptive immunity -- 31 Human and mouse memory-type pathogenic Th2 (Tpath2) cells in airway inflammation -- 32 Controlling the mechanism underlying chronic inflammation through the epigenetic modulation of CD4 T cell senescence -- 33 Adrenergic control of lymphocyte dynamics and inflammation -- 34 The multifaceted role of PD-1 in health and Disease -- 35 The role of lysophospholipids in immune cell trafficking and inflammation -- Part 7. Chronic inflammation and autoimmune diseases -- 36 Devising novel methods to control chronic inflammation via regulatory T cells -- 37 Control of chronic inflammation through elucidation of organ-specific autoimmune disease mechanisms -- 38 Lysophosphatidylserine as an inflammatory mediator -- 39 Aberrant activation of RIG-I like receptors and autoimmune diseases -- 40 Elucidation of the exacerbation mechanism of autoimmune diseases caused by disruption of the ion homeostasis -- Part 8. Chronic inflammation and aging -- 41 Pathophysiological role of chronic inflammation in aging-associated diseases -- 42 Uterine cellular senescence in the mouse model of preterm birth -- Part 9. Chronic inflammation and bowel diseases -- 43 Physiological and Pathological Inflammation at the Mucosal Frontline -- 44 Control of intestinal regulatory T cells by human commensal bacteria -- 45 Roles of the epithelial autophagy in the intestinal mucosal barrier -- 46 Development of sentinel-cell targeted therapy for inflammatory bowel diseases -- 47 Identification of long non-coding RNAs involved in chronic inflammation in Helicobacter pylori infection and associated gastric carcinogenesis -- Part 10. Chronic inflammation and central nervous system disease -- 48 The research for the mechanism of chronically intractable pain based on the functions of microglia as brain immunocompetent cell -- 49 The role of innate immunity in ischemic stroke -- 50 Chronic neuroinflammation underlying pathogenesis of Alzheimer's disease -- Part 11. Chronic inflammation and cardiovascular diseases -- 51 The roles of hypoxic responses during the pathogenesis of cardiovascular diseases -- 52 Prevention and treatment of heart failure based on the control of inflammation.
000763666 506__ $$aAccess limited to authorized users.
000763666 588__ $$aOnline resource; title from PDF title page (viewed November 9, 2016)
000763666 650_0 $$aInflammation$$xImmunological aspects.
000763666 650_0 $$aInflammation$$xTreatment.
000763666 650_0 $$aChronic diseases.
000763666 7001_ $$aMiyasaka, Masayuki,$$eeditor.
000763666 7001_ $$aTakatsu, Kiyoshi,$$d1944-$$eeditor.
000763666 77608 $$iPrint version:$$z9784431560661$$z4431560661$$w(OCoLC)944473972
000763666 852__ $$bebk
000763666 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-4-431-56068-5$$zOnline Access$$91397441.1
000763666 909CO $$ooai:library.usi.edu:763666$$pGLOBAL_SET
000763666 980__ $$aEBOOK
000763666 980__ $$aBIB
000763666 982__ $$aEbook
000763666 983__ $$aOnline
000763666 994__ $$a92$$bISE